Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.46 USD | -0.51% | +8.11% | -8.59% |
May. 08 | Transcript : Arcus Biosciences, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q1 Revenue $145M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.59% | 1.59B | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+48.60% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- RCUS Stock
- News Arcus Biosciences, Inc.
- Goldman Sachs Adjusts Arcus Biosciences Price Target to $28 From $48, Maintains Neutral Rating